Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $37.3000 (4.19%) ($35.6000 - $37.6500) on Wed. Feb. 7, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.79% (three month average) | RSI | 71 | Latest Price | $37.3000(4.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -2.895% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) UNG(-5%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.895% (StdDev 5.79%) | Hourly BBV | 0 () | Intraday Trend | 3.9% | | | |
|
5 Day Moving Average | $35(6.57%) | 10 Day Moving Average | $36.17(3.12%) | 20 Day Moving Average | $32.67(14.17%) | To recent high | -7.3% | To recent low | 182.6% | Market Cap | $2.772b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |